Method
COPD, diabetes
COPD, EMERGENCY, DIABETES
This pilot randomised controlled trial with an economic analysis conducted alongside compared the PHC intervention against usual care [Patients diagnosed with COPD and/or diabetes from the Barwon Health region were eligible for the study if they had a high likelihood of hospital readmission (predicted by PRaDA) over the next 12 months [Patients randomised to the intervention were provided with clinical monitoring equipment depending on diagnosis (blood glucose monitors, blood pressure monitors and/or pulse oximeters), a tablet device with internet connection [Participants randomised to the control group received usual care. In both study groups, patients were advised that if their condition deteriorated or they experienced an acute exacerbation, they should seek medical advice as usual (via Emergency Department (ED) or General Practitioner).The intervention costs and hospital admission data pertaining to study participants were collected from the study team and hospital costing team.All data were re-organised according to an economic evaluation plan and transferred to Stata®13, Stata®14 and SPSS®24 format for cleaning and analysis. T-tests and 95% Confidence Intervals (CI) were used for the comparison of mean total cost, length of stay (LOS) and QALYs between the study groups.